Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

BETON O., Saricam E., KAYA H., YÜCEL H., Dogdu O., TURGUT O. O., ...Daha Fazla

BMC CARDIOVASCULAR DISORDERS, cilt.16, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1186/s12872-016-0251-1
  • Dergi Adı: BMC CARDIOVASCULAR DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Cardiac electronic device implantation, Topical tranexamic acid, Antithrombotic therapy, Pocket hematoma, Major bleeding complications, DEFIBRILLATOR SURGERY, POCKET HEMATOMA, PACEMAKER, CLOPIDOGREL, RISK
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: The perioperative use of antithrombotic therapy is associated with increased bleeding risk after cardiac implantable electronic device (CIED) implantation. Topical application of tranexamic acid (TXA) is effective in reducing bleeding complications after various surgical operations. However, there is no information regarding local TXA application during CIED procedures. The purpose of our study was to evaluate bleeding complications rates during CIED implantation with and without topical TXA use in patients receiving antithrombotic treatment.